Drug Type Small molecule drug |
Synonyms AB 19( AptaBio), AB19( AptaBio) |
Target |
Action inhibitors |
Mechanism NOX inhibitors(NADPH oxidase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hematologic Neoplasms | Preclinical | South Korea | 07 Jun 2024 | |
| Solid tumor | Preclinical | South Korea | 07 Jun 2024 | |
| Wet age-related macular degeneration | Preclinical | South Korea | 07 Jun 2024 |





